ALL Medical Research, LLC

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes3 trials
• High blood pressure2 trials
• Chronic kidney disease1 trial
• Familial hypercholesterolaemia1 trial
• Heart failure1 trial
• Obesity1 trial
• Type 1 diabetes1 trial

Phase

• Phase 23 trials
• Phase 32 trials
• Phase 41 trial

Status

• Active, not recruiting3 trials
• Completed2 trials
• Recruiting1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• Novartis Pharmaceuticals2 trials
• Applied Therapeutics, Inc.1 trial
• Inversago Pharma Inc.1 trial

Running trials

• Recruiting

  A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia

  NCT07610278· Phase 2· Novartis Pharmaceuticals· Source

  Contact: Alejandro Marin

• Active, not recruiting

  A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients

  NCT06857955· Phase 2· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity

  NCT06859268· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy

  NCT04083339· Phase 3· Applied Therapeutics, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Familial hypercholesterolaemia1 recruiting
• High blood pressure1 recruiting

Closed trials

• Completed

  A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)

  NCT05564039· Phase 4· Eli Lilly and Company· Source

• Completed

  Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

  NCT05514548· Phase 2· Inversago Pharma Inc.· Source